GLP-1 microdosing may appeal to people who are interested in metabolic support but are cautious about traditional higher-dose protocols
In fact, a study looking at people who used semaglutide showed that lost up to 7 kg or 15 lbs of muscle mass over the course of treatment
While the overall risk appears to be small, I now screen more carefully for patients with risk factors such as pre-existing optic nerve problems, glaucoma, or significant diabetic retinopathy. Recent research also connects liraglutide, the active ingredient in Saxenda and Victoza, to similar concerns
Accumulating evidence suggests that this pathway plays an essential role in the pathogenesis of several age-related diseases including cancer, dementia, cardiovascular, and metabolic diseases
Partager ce contenu lire aussi La Caisse dassurance vieillesse des pharmaciens (CAVP) rforme les barmes des classes de cotisation du rgime compl